{
  "resourceType" : "MedicationRequest",
  "id" : "mii-exa-medikation-medication-request-caelyx",
  "meta" : {
    "profile" : ["https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationRequest|2027.0.0-ballot"],
    "security" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/v3-ActReason",
      "code" : "HTEST",
      "display" : "test health data"
    }]
  },
  "language" : "de",
  "text" : {
    "status" : "extensions",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest mii-exa-medikation-medication-request-caelyx</b></p><a name=\"de-mii-exa-medikation-medication-request-caelyx\"> </a><a name=\"de-hcmii-exa-medikation-medication-request-caelyx\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-medikation-medication-request.html\">MII PR Medikation MedicationRequest</a> version: 2027.0.0-ballot</p><p style=\"margin-bottom: 0px\">Security Label: <a href=\"http://terminology.hl7.org/7.3.0/CodeSystem-v3-ActReason.html\">test health data (Details: ActReason code HTEST = 'test health data')</a></p></div><p><b>R5: Full representation of the dosage instructions (new)</b>: </p><div><p>Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion</p>\n</div><p><b>status</b>: Active</p><p><b>intent</b>: Order</p><p><b>medication</b>: <a href=\"Medication-mii-exa-medikation-medication-caelyx.html\">Medication Caelyx pegylated liposomal 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1x25ml DSF N1</a></p><p><b>subject</b>: <a href=\"Patient-mii-exa-medikation-patient.html\">Max Mustermann  Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)</a></p><p><b>authoredOn</b>: 2021-12-21 11:41:00+0100</p><blockquote><p><b>dosageInstruction</b></p><p><b>timing</b>: Once per 4 weeks</p><p><b>route</b>: <span title=\"Codes:{http://standardterms.edqm.eu 20045000}\">Intravenous use</span></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>50 mg/m2 BSA<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codemg/m2 = 'mg/m2')</span></td></tr></table></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/5.0/StructureDefinition/extension-MedicationRequest.renderedDosageInstruction",
    "valueMarkdown" : "Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion"
  }],
  "status" : "active",
  "intent" : "order",
  "medicationReference" : {
    "reference" : "Medication/mii-exa-medikation-medication-caelyx"
  },
  "subject" : {
    "reference" : "Patient/mii-exa-medikation-patient"
  },
  "authoredOn" : "2021-12-21T11:41:00+01:00",
  "dosageInstruction" : [{
    "timing" : {
      "repeat" : {
        "frequency" : 1,
        "period" : 4,
        "periodUnit" : "wk"
      }
    },
    "route" : {
      "coding" : [{
        "system" : "http://standardterms.edqm.eu",
        "code" : "20045000",
        "display" : "Intravenous use"
      }]
    },
    "doseAndRate" : [{
      "doseQuantity" : {
        "value" : 50,
        "unit" : "mg/m2 BSA",
        "system" : "http://unitsofmeasure.org",
        "code" : "mg/m2"
      }
    }]
  }]
}